Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: J Allergy Clin Immunol. 2015 Jun 1;136(6):1673–79.e1-3. doi: 10.1016/j.jaci.2015.04.024

TABLE III.

Symptom resolution score and change in serum tryptase levels over time

Follow-up time (y) by resolution status, mean (no.)
 Percentage decrease in serum tryptase levels by resolution status, mean (no.)
Disease Complete Major Partial Complete Major Partial
UP 1.8 (1) 6.1 (12) 7.3 (6) 86.3 (1) 43.7 (12) 32.8 (6)
DCM — 7.4 (4) 3.1 (3) — 74.6 (4) 34.4 (3)
ISM 10.4 (1) 5.8 (3) 6.5 (7) 66.3 (1) 43.9 (3) 23.9 (7)
All 6.1 (2) 6.3 (19) 6.1 (16) 76.3 (2) 50.3 (19) 29.2 (16)

One child with the nodular form of maculopapular cutaneous mastocytosis had a major remission from the nodular subtype to maculopapular cutaneous mastocytosis and a decrease in serum tryptase level from 86.2 to 30.6 ng/mL.